Luther King Capital Management (LKCM)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $60.2M | Sell |
2,498,042
-100,898
| -4% | -$2.64M | 0.25% | 81 |
|
|
2026
Q1 | $73M | Buy |
2,598,940
+10,298
| +0.4% | +$274K | 0.32% | 75 |
|
|
2025
Q4 | $64.5M | Sell |
2,588,642
-117,825
| -4% | -$2.97M | 0.26% | 80 |
|
|
2025
Q3 | $69M | Sell |
2,706,467
-14,810
| -0.5% | -$366K | 0.28% | 77 |
|
|
2025
Q2 | $66M | Buy |
2,721,277
+22,345
| +0.8% | +$521K | 0.29% | 80 |
|
|
2025
Q1 | $68.4M | Buy |
2,698,932
+163,847
| +6% | +$4.29M | 0.32% | 77 |
|
|
2024
Q4 | $67.3M | Buy |
2,535,085
+34,070
| +1% | +$924K | 0.29% | 78 |
|
|
2024
Q3 | $72.4M | Buy |
2,501,015
+143,833
| +6% | +$4.2M | 0.31% | 75 |
|
|
2024
Q2 | $66M | Buy |
2,357,182
+207,837
| +10% | +$5.72M | 0.3% | 74 |
|
|
2024
Q1 | $59.6M | Buy |
2,149,345
+138,329
| +7% | +$3.84M | 0.27% | 84 |
|
|
2023
Q4 | $57.9M | Buy |
2,011,016
+11,863
| +0.6% | +$359K | 0.28% | 80 |
|
|
2023
Q3 | $66.3M | Sell |
1,999,153
-78,140
| -4% | -$2.76M | 0.34% | 70 |
|
|
2023
Q2 | $76.2M | Sell |
2,077,293
-107,595
| -5% | -$4.19M | 0.38% | 71 |
|
|
2023
Q1 | $89.1M | Sell |
2,184,888
-92,248
| -4% | -$3.98M | 0.47% | 66 |
|
|
2022
Q4 | $117M | Sell |
2,277,136
-2,617
| -0.1% | -$125K | 0.64% | 53 |
|
|
2022
Q3 | $99.8M | Sell |
2,279,753
-3,846
| -0.2% | -$187K | 0.6% | 53 |
|
|
2022
Q2 | $120M | Sell |
2,283,599
-6,795
| -0.3% | -$346K | 0.67% | 45 |
|
|
2022
Q1 | $119M | Buy |
2,290,394
+10,339
| +0.5% | +$536K | 0.58% | 56 |
|
|
2021
Q4 | $135M | Buy |
2,280,055
+22,664
| +1% | +$1.12M | 0.61% | 49 |
|
|
2021
Q3 | $97.1M | Sell |
2,257,391
-133,942
| -6% | -$5.93M | 0.48% | 68 |
|
|
2021
Q2 | $93.6M | Sell |
2,391,333
-55,044
| -2% | -$2.14M | 0.46% | 71 |
|
|
2021
Q1 | $88.6M | Sell |
2,446,377
-60,669
| -2% | -$2.15M | 0.48% | 67 |
|
|
2020
Q4 | $92.3M | Sell |
2,507,046
-200,152
| -7% | -$7.34M | 0.52% | 59 |
|
|
2020
Q3 | $94.3M | Buy |
2,707,198
+19,967
| +0.7% | +$700K | 0.6% | 52 |
|
|
2020
Q2 | $83.4M | Sell |
2,687,231
-461,921
| -15% | -$15.7M | 0.58% | 53 |
|
|
2020
Q1 | $97.5M | Buy |
3,149,152
+86,505
| +3% | +$2.95M | 0.84% | 38 |
|
|
2019
Q4 | $114M | Sell |
3,062,647
-1,542
| -0.1% | -$54.9K | 0.76% | 44 |
|
|
2019
Q3 | $104M | Buy |
3,064,189
+5,131
| +0.2% | +$187K | 0.76% | 47 |
|
|
2019
Q2 | $126M | Sell |
3,059,058
-26,014
| -0.8% | -$1.03M | 0.92% | 40 |
|
|
2019
Q1 | $124M | Sell |
3,085,072
-37,518
| -1% | -$1.5M | 0.95% | 41 |
|
|
2018
Q4 | $129M | Sell |
3,122,590
-16,460
| -0.5% | -$683K | 1.15% | 32 |
|
|
2018
Q3 | $131M | Sell |
3,139,050
-97,402
| -3% | -$3.75M | 0.99% | 34 |
|
|
2018
Q2 | $111M | Sell |
3,236,452
-157,529
| -5% | -$5.38M | 0.91% | 41 |
|
|
2018
Q1 | $114M | Sell |
3,393,981
-389
| -0% | -$13.4K | 0.96% | 37 |
|
|
2017
Q4 | $117M | Buy |
3,394,370
+455,827
| +16% | +$15.5M | 0.95% | 36 |
|
|
2017
Q3 | $99.5M | Sell |
2,938,543
-71,544
| -2% | -$2.3M | 0.87% | 46 |
|
|
2017
Q2 | $95.9M | Sell |
3,010,087
-59,283
| -2% | -$1.87M | 0.87% | 44 |
|
|
2017
Q1 | $99.6M | Sell |
3,069,370
-96,805
| -3% | -$3.05M | 0.92% | 42 |
|
|
2016
Q4 | $97.6M | Buy |
3,166,175
+8,650
| +0.3% | +$264K | 0.93% | 41 |
|
|
2016
Q3 | $101M | Buy |
3,157,525
+8,542
| +0.3% | +$286K | 0.99% | 35 |
|
|
2016
Q2 | $105M | Sell |
3,148,983
-1,334
| -0% | -$42.6K | 1.03% | 33 |
|
|
2016
Q1 | $88.6M | Sell |
3,150,317
-7,403
| -0.2% | -$211K | 0.88% | 42 |
|
|
2015
Q4 | $96.7M | Sell |
3,157,720
-61,276
| -2% | -$1.93M | 0.91% | 36 |
|
|
2015
Q3 | $95.9M | Buy |
3,218,996
+57,774
| +2% | +$1.85M | 0.93% | 35 |
|
|
2015
Q2 | $101M | Sell |
3,161,222
-218,664
| -6% | -$7.13M | 0.87% | 40 |
|
|
2015
Q1 | $112M | Buy |
3,379,886
+42,139
| +1% | +$1.34M | 0.93% | 37 |
|
|
2014
Q4 | $98.6M | Sell |
3,337,747
-4,412
| -0.1% | -$127K | 0.8% | 42 |
|
|
2014
Q3 | $93.8M | Sell |
3,342,159
-87,460
| -3% | -$2.45M | 0.77% | 43 |
|
|
2014
Q2 | $96.6M | Buy |
3,429,619
+86,672
| +3% | +$2.47M | 0.76% | 45 |
|
|
2014
Q1 | $102M | Buy |
3,342,947
+21,958
| +0.7% | +$655K | 0.83% | 34 |
|
|
2013
Q4 | $96.5M | Sell |
3,320,989
-13,814
| -0.4% | -$402K | 0.78% | 37 |
|
|
2013
Q3 | $90.9M | Buy |
3,334,803
+60,402
| +2% | +$1.64M | 0.78% | 34 |
|
|
2013
Q2 | $87M | Buy |
+3,274,401
| New | +$90.5M | 0.81% | 32 |
|
Other funds holding PFE
Luther King Capital Management (LKCM)'s PFE Position: Q2 2026 in Review
Luther King Capital Management (LKCM) reduced its Pfizer (PFE) stake by 3.9% in Q2 2026, selling an estimated $2.64M and leaving 2,498,042 shares worth $60.2M. The position accounts for 0.25% of the portfolio, ranked #81.
Luther King Capital Management (LKCM) first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $135M in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Luther King Capital Management (LKCM) held 2,498,042 shares of Pfizer worth $60.2M as of Q2 2026.
- Luther King Capital Management (LKCM) sold 100,898 Pfizer shares in Q2 2026, an estimated $2.64M.
- Pfizer made up 0.25% of Luther King Capital Management (LKCM)'s portfolio in Q2 2026, its #81 holding.
- Luther King Capital Management (LKCM) first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Luther King Capital Management (LKCM)'s Pfizer position peaked at $135M in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Luther King Capital Management (LKCM)'s 13F filing for Q2 2026, filed 10 Aug 2026.